Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Vir Biotechnology (Nasdaq: VIR) announced CEO Marianne De Backer will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference. The event is scheduled for June 12 at 11:00 a.m. PT / 2:00 p.m. ET at the Loews Miami Beach Hotel. The discussion will be webcast live and archived for 30 days on the Vir website.
- Participation in a high-profile event like the Goldman Sachs Annual Global Healthcare Conference can increase visibility and credibility for Vir Biotechnology.
- Having the CEO participate in the event demonstrates strong leadership and may instill investor confidence.
- No new data, financial updates, or breakthrough announcements were disclosed in the PR.
- The webcast will only be available for 30 days, potentially limiting long-term investor engagement.
A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is an immunology company focused on powering the immune system to transform lives by treating and preventing infectious diseases and other serious conditions, including viral-associated diseases. Vir has assembled two technology platforms that are designed to modulate the immune system by exploiting critical observations of natural immune processes. Its current clinical development pipeline consists of product candidates targeting hepatitis delta and hepatitis B viruses and human immunodeficiency virus. Vir has several preclinical candidates in its pipeline, including those targeting influenza A and B, COVID-19, RSV/MPV and HPV. Vir routinely posts information that may be important to investors on its website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529942722/en/
Media
Carly Scaduto
Senior Director, Media Relations
cscaduto@vir.bio
+1 314-368-5189
Investors
Richard Lepke
Senior Director, Investor Relations
rlepke@vir.bio
+1 978-973-9986
Source: Vir Biotechnology, Inc.
FAQ
When is Vir Biotechnology's fireside chat at the Goldman Sachs Healthcare Conference?
Where is the Goldman Sachs 45th Annual Global Healthcare Conference held?
Will the Vir Biotechnology fireside chat be available online?
